1. Home
  2. PRAX vs DUOL Comparison

PRAX vs DUOL Comparison

Compare PRAX & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$289.43

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Duolingo Inc.

DUOL

Duolingo Inc.

HOLD

Current Price

$100.53

Market Cap

8.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
DUOL
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.4B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PRAX
DUOL
Price
$289.43
$100.53
Analyst Decision
Strong Buy
Buy
Analyst Count
15
18
Target Price
$572.13
$176.88
AVG Volume (30 Days)
308.0K
2.9M
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
355.85
EPS
N/A
8.57
Revenue
N/A
$1,037,589,000.00
Revenue This Year
N/A
$19.80
Revenue Next Year
$6,395.88
$14.64
P/E Ratio
N/A
$11.66
Revenue Growth
N/A
38.71
52 Week Low
$26.70
$91.99
52 Week High
$354.87
$544.93

Technical Indicators

Market Signals
Indicator
PRAX
DUOL
Relative Strength Index (RSI) 37.95 40.28
Support Level $266.93 $91.99
Resistance Level $322.32 $118.42
Average True Range (ATR) 16.36 5.56
MACD -4.02 1.85
Stochastic Oscillator 4.20 49.08

Price Performance

Historical Comparison
PRAX
DUOL

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: